Webinar: The Inflation Reduction Act (IRA)

H. John Beardsley is Senior Vice President of Corporate Strategy and Business Development at CoverMyMeds. In this role, John is responsible for analyzing market trends and investigating potential partnerships that can yield greater value for customers and patients. John has more than 25 years of experience in health insurance, pharmacy, financial services, and healthcare technology. Throughout his career, he has focused on strengthening the connections between pharmacies, health systems, insurers and pharma companies to improve patient care.

Fauzea Hussain is the Vice President of Public Policy at McKesson, where she champions public policy strategies that drive the company's mission to improve health outcomes. With a keen focus on patient-first solutions, Fauzea collaborates across the enterprise to address the diverse needs of distributors, wholesalers, community providers, health systems, pharmacies, manufacturers, technology vendors and consumers. A seasoned policy expert with over 25 years of experience, Fauzea has a proven track record in assessing the impact of state and federal policies on patient access, provider reimbursement, and the life sciences industry.

Ashwin Singhania has over 20 years of experience in life sciences advising biopharma companies to support their strategic growth in bringing new products to market to enhance patient care. As a principal within Strategy and Transactions at EY-Parthenon, Ernst & Young LLP, Ashwin focuses on corporate and commercial strategy for biopharma across growth strategy, transaction support and operating model transformation. His career includes roles with large pharmaceutical organizations, specialty pharmaceuticals and prerevenue biotechs. He also supports private equity for investments in biopharmaceutical and biopharmaceutical services.